进一步加强慢性肝炎、肝纤维化治疗研究

Progress in the treatment of hepatitis B and digestive tumors with cantharidin and its analogues

Blister beetle or mylabris, pungent in flavor and toxic in nature, has been used for more than 2000 years as traditional Chinese medicine in China. Cantharidin, an active ingredient of the blister beetle, is an effective therapeutic agent against cancers of the liver, breast, esophagus, lung and intestine, etc. However, it is very toxic. Nocantharidin (NCTD), a derivative of cantharidin first synthesized in China, is a new anti-tumor drug with strong anti-tumor activities and increases the number of while blood cells. Cantharidin can be used in the treatment of hepatitis B and pointed condyloma. This paper reviews the progress in its clinical applications at home and abroad.

Potential effect of specific immunotherapy on chronic hepatitis B of vertical maternal-fetal transmission: an analysis of 23 cases

AIM: To study the efficacy of specific immuno-therapy in the treatment of patients with chronic hepatitis B (CHB) of vertical maternal-fetal transmission.

METHODS: HBsAg vaccine-loaded dendritic cells (DC, 10⁶) and HBIg (200 U) were injected respectively into 23 patients with CHB of vertical transmission. Six months were considered as one course, and there were two courses in total. At the end of treatment, liver function, HBV DNA level and HBV markers in the patients were measured.

RESULTS: Of the 9 patients with HBeAg(+) CHB, 1 case showed a complete response, and 7 showed partial responses. Of the 4 patients with HBeAg(-) CHB, partial responses occurred in 2 cases. No responses were observed in the 5 chronic HBV carriers. Of the 5 inactive HBsAg carriers, 1 case showed a complete response, while the rest showed no responses.

CONCLUSION: The specific immunotherapy is effective in the treatment of CHB transmitted from the mothers.

N/A

N/A